loading
Precedente Chiudi:
$0.2875
Aprire:
$0.2877
Volume 24 ore:
107.99K
Relative Volume:
0.03
Capitalizzazione di mercato:
$2.96M
Reddito:
-
Utile/perdita netta:
$-22.70M
Rapporto P/E:
-0.0674
EPS:
-4.38
Flusso di cassa netto:
$-26.07M
1 W Prestazione:
+8.19%
1M Prestazione:
-39.15%
6M Prestazione:
-99.11%
1 anno Prestazione:
-99.57%
Intervallo 1D:
Value
$0.283
$0.30
Intervallo di 1 settimana:
Value
$0.25
$0.31
Portata 52W:
Value
$0.25
$79.50

Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile

Name
Nome
Hepion Pharmaceuticals Inc
Name
Telefono
732-902-4000
Name
Indirizzo
399 THORNALL STREET, EDISON
Name
Dipendente
22
Name
Cinguettio
@HepionPharma
Name
Prossima data di guadagno
2024-11-18
Name
Ultimi documenti SEC
Name
HEPA's Discussions on Twitter

Confronta HEPA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
HEPA
Hepion Pharmaceuticals Inc
0.29 2.96M 0 -22.70M -26.07M -4.38
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.32 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
608.19 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
619.59 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.66 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
251.90 24.70B 3.81B -644.79M -669.77M -6.24

Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-07-20 Ripresa ROTH Capital Buy

Hepion Pharmaceuticals Inc Borsa (HEPA) Ultime notizie

pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 22, 2025

Holdings of Hepion Pharmaceuticals Inc (HEPA) are aligned with the stars - Sete News

Apr 22, 2025
pulisher
Apr 17, 2025

Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 2% – What’s Next? - Defense World

Apr 17, 2025
pulisher
Apr 10, 2025

Hepion Pharmaceuticals (HEPA) Ends Merger with Pharma Two B - GuruFocus

Apr 10, 2025
pulisher
Apr 10, 2025

Hepion Pharmaceuticals (HEPA) Announces $9M Public Offering Laun - GuruFocus

Apr 10, 2025
pulisher
Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

Hepion Pharmaceuticals to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference - ACCESS Newswire

Apr 09, 2025
pulisher
Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

Pharma Two B Presents Positive P2B001 Data for Parkinson's Disea - GuruFocus

Apr 09, 2025
pulisher
Apr 09, 2025

Hepion Pharmaceuticals (HEPA) to Implement 1-for-50 Reverse Stoc - GuruFocus

Apr 09, 2025
pulisher
Apr 08, 2025

Hepion Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Apr 08, 2025
pulisher
Apr 07, 2025

HEPA stock touches 52-week low at $0.39 amid sharp annual decline - Investing.com Canada

Apr 07, 2025
pulisher
Apr 01, 2025

Before You Invest, Make Sure You Check This Hepion Pharmaceuticals Inc (NASDAQ: HEPA) Analysis - Stocksregister

Apr 01, 2025
pulisher
Apr 01, 2025

Hepion Pharmaceuticals Delays Annual Report Filing - TipRanks

Apr 01, 2025
pulisher
Mar 28, 2025

Hepion Pharmaceuticals announces 1-for-50 reverse stock split - MSN

Mar 28, 2025
pulisher
Mar 25, 2025

HEPA stock plunges to 52-week low, touches $0.67 By Investing.com - Investing.com UK

Mar 25, 2025
pulisher
Mar 25, 2025

Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Price Down 7.2% – Here’s Why - Defense World

Mar 25, 2025
pulisher
Mar 21, 2025

Hepion Pharmaceuticals faces potential Nasdaq delisting By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 20, 2025

Hepion Pharmaceuticals faces potential Nasdaq delisting - Investing.com

Mar 20, 2025
pulisher
Mar 19, 2025

Hepion Pharmaceuticals enacts reverse stock split By Investing.com - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Hepion Pharmaceuticals enacts reverse stock split - Investing.com

Mar 19, 2025
pulisher
Mar 17, 2025

Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split Effective March 17, 2025 - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Upcoming Stock Splits This Week (March 17 to March 21) – Stay Invested - The Globe and Mail

Mar 17, 2025
pulisher
Mar 14, 2025

Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split - ROI-NJ.com

Mar 14, 2025
pulisher
Mar 14, 2025

Hepion Pharmaceuticals Announces 1-for-50 Reverse Stock Split To Maintain Nasdaq Listing - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

Hepion Pharmaceuticals enacts reverse stock split to meet NASDAQ requirements By Investing.com - Investing.com South Africa

Mar 14, 2025
pulisher
Mar 14, 2025

Hepion Pharmaceuticals Announces Reverse Stock Split - citybiz

Mar 14, 2025
pulisher
Mar 14, 2025

Hepion Plans Massive 1:50 Reverse Split to Save NASDAQ ListingWhat Shareholders Must Know - StockTitan

Mar 14, 2025
pulisher
Mar 13, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga India

Mar 13, 2025
pulisher
Mar 12, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Pre-market Movers: HCTI, HEPA, ZYXI, SYRS ... - RTTNews

Mar 12, 2025
pulisher
Mar 11, 2025

An In-Depth Look At Hepion Pharmaceuticals Inc (HEPA) - Marketing Sentinel

Mar 11, 2025
pulisher
Mar 11, 2025

HEPA stock plunges to 52-week low, touches $0.08 - Investing.com Australia

Mar 11, 2025
pulisher
Mar 10, 2025

HEPA stock plunges to 52-week low, touches $0.08 By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 05, 2025

Hepion Pharmaceuticals releases unaudited balance sheet - Investing.com India

Mar 05, 2025
pulisher
Mar 01, 2025

Hepion Pharmaceuticals Announces Publication in Expert Opinion on Investigational Drugs - ACCESS Newswire

Mar 01, 2025
pulisher
Feb 28, 2025

HEPA stock touches 52-week low at $0.12 amid sharp decline - Investing.com Canada

Feb 28, 2025
pulisher
Feb 27, 2025

Hepion Pharmaceuticals Successfully Advances to Next Dosing Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431 - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 11, 2025

Hepion Pharmaceuticals (NASDAQ:HEPA) Shares Up 1.3% – Here’s Why - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

The HEPA Stock Puzzle: Unraveling Hepion Pharmaceuticals Inc’s Fluctuating Performance - The InvestChronicle

Feb 10, 2025

Hepion Pharmaceuticals Inc Azioni (HEPA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Capitalizzazione:     |  Volume (24 ore):